Cortechs.ai | Case Study: NeuroQuant® Lesion Surveillance: Monitoring Lesions Related to Anti-Amyloid Therapy in Early Alzheimer’s Disease
RSNA 2025
Contact
  • Home
  • /
  • Resources
  • /
  • Case Study: NeuroQuant® Lesion Surveillance: Monitoring Lesions Related to Anti-Amyloid Therapy in Early Alzheimer’s Disease

Case Study: NeuroQuant® Lesion Surveillance: Monitoring Lesions Related to Anti-Amyloid Therapy in Early Alzheimer’s Disease

  • Category: Case studies
  • Product: NeuroQuant Lesion Surveillance
  • Disease: Alzheimer's disease, ARIA, Neurodementias

Fill out the form below to read this case study:


  • Topic: Case studies

More Resources

Cortechs.ai | Case Study: NeuroQuant® Lesion Surveillance: Monitoring Lesions Related to Anti-Amyloid Therapy in Early Alzheimer’s Disease
  • 3 mins

08/19/2026

Brain Metastases Imaging Insights from SNO/ASCO 2026

Explore key insights from SNO/ASCO 2026 on brain metastases imaging, including lesion tracking, volumetric analysis, SRS workflows, and automated segmentation.

Cortechs.ai | Case Study: NeuroQuant® Lesion Surveillance: Monitoring Lesions Related to Anti-Amyloid Therapy in Early Alzheimer’s Disease
  • 2 mins

08/18/2026

Cortechs.ai Announces FDA Clearance for NeuroQuant® PET: Advancing Molecular Imaging for Cognitive Impairment

NeuroQuant® PET receives FDA 510(k) clearance, advancing quantitative PET imaging for cognitive impairment.

,

Cortechs.ai | Case Study: NeuroQuant® Lesion Surveillance: Monitoring Lesions Related to Anti-Amyloid Therapy in Early Alzheimer’s Disease
  • 3 mins

08/04/2026

Cortechs.ai Expands European CE Marking Across AI Imaging Platform, Accelerating Global Growth

Cortechs.ai expands EU CE Marking for the latest NeuroQuant®, NeuroQuant® Brain Tumor, and OnQ™ Prostate, advancing global AI imaging innovation

,

Cortechs.ai | Case Study: NeuroQuant® Lesion Surveillance: Monitoring Lesions Related to Anti-Amyloid Therapy in Early Alzheimer’s Disease
  • 3 mins

07/29/2026

Read Your Segmentations in the Same Space You Read the Study: Native Space Outputs in NeuroQuant v5.3.0

Review lesion segmentations directly on your original MRI images with NeuroQuant® v5.3.0.

Cortechs.ai | Case Study: NeuroQuant® Lesion Surveillance: Monitoring Lesions Related to Anti-Amyloid Therapy in Early Alzheimer’s Disease
  • 3 mins

07/23/2026

What AAIC 2026 Told Us About the Future of Dementia Imaging — And Where NeuroQuant Fits

Quantitative MRI brain volumetry with NeuroQuant.

Cortechs.ai | Case Study: NeuroQuant® Lesion Surveillance: Monitoring Lesions Related to Anti-Amyloid Therapy in Early Alzheimer’s Disease
  • 2 mins

07/09/2026

Viz.ai Expands into Neurodegenerative Disease with Cortechs.ai Collaboration

Cortechs.ai and Viz.ai partner to tackle multiple sclerosis and other neurodegenerative diseases across Viz.ai’s health system network

,

View our insights
Scroll to Top